this post was submitted on 07 Jun 2024
90 points (97.9% liked)

News

22595 readers
4447 users here now

Welcome to the News community!

Rules:

1. Be civil


Attack the argument, not the person. No racism/sexism/bigotry. Good faith argumentation only. This includes accusing another user of being a bot or paid actor. Trolling is uncivil and is grounds for removal and/or a community ban.


2. All posts should contain a source (url) that is as reliable and unbiased as possible and must only contain one link.


Obvious right or left wing sources will be removed at the mods discretion. We have an actively updated blocklist, which you can see here: https://lemmy.world/post/2246130 if you feel like any website is missing, contact the mods. Supporting links can be added in comments or posted seperately but not to the post body.


3. No bots, spam or self-promotion.


Only approved bots, which follow the guidelines for bots set by the instance, are allowed.


4. Post titles should be the same as the article used as source.


Posts which titles don’t match the source won’t be removed, but the autoMod will notify you, and if your title misrepresents the original article, the post will be deleted. If the site changed their headline, the bot might still contact you, just ignore it, we won’t delete your post.


5. Only recent news is allowed.


Posts must be news from the most recent 30 days.


6. All posts must be news articles.


No opinion pieces, Listicles, editorials or celebrity gossip is allowed. All posts will be judged on a case-by-case basis.


7. No duplicate posts.


If a source you used was already posted by someone else, the autoMod will leave a message. Please remove your post if the autoMod is correct. If the post that matches your post is very old, we refer you to rule 5.


8. Misinformation is prohibited.


Misinformation / propaganda is strictly prohibited. Any comment or post containing or linking to misinformation will be removed. If you feel that your post has been removed in error, credible sources must be provided.


9. No link shorteners.


The auto mod will contact you if a link shortener is detected, please delete your post if they are right.


10. Don't copy entire article in your post body


For copyright reasons, you are not allowed to copy an entire article into your post body. This is an instance wide rule, that is strictly enforced in this community.

founded 1 year ago
MODERATORS
top 10 comments
sorted by: hot top controversial new old
[–] [email protected] 28 points 2 months ago (1 children)

Big fucking news for the IBS/D crowd, and I'm one of em.

[–] [email protected] -5 points 2 months ago (1 children)

Do you think you will be able to afford it?

[–] [email protected] 10 points 2 months ago (1 children)

Meh. I have mine mostly under control so if they price it out of reach, so be it.

But given that the article says it's reformulating existing drugs to work here, they may be considerably cheaper than expected.

[–] [email protected] 8 points 2 months ago (1 children)

The fact this has to be a concern is so depressing....

[–] [email protected] 1 points 2 months ago

Yes, but the guy raising the concern may just have an ax to grind about the state of US healthcare.

[–] [email protected] 14 points 2 months ago* (last edited 2 months ago)

The Fisher King to Perceval: “The real Holy Grail was the irritable bowel syndrome we acquired along the way.”

[–] [email protected] 10 points 2 months ago

Researchers have discovered a key biological pathway that drives inflammatory bowel disease (IBD) and other autoimmune disorders. This breakthrough centers on a gene called ETS2 that regulates the inflammatory behavior of immune cells called macrophages. The same pathway is thought to underlie conditions like ankylosing spondylitis and autoimmune liver and artery diseases. Existing cancer drugs called MEK inhibitors can dampen the activity of ETS2, suggesting a potential treatment approach. The researchers are now working to develop a targeted version of these drugs to treat IBD and related conditions, with clinical trials expected within 5 years. This discovery represents a major advance in understanding the fundamental causes of IBD and other immune disorders.

Kagi Summarized

[–] [email protected] 6 points 2 months ago

no enough superlatives on the title for me to click on the link

[–] [email protected] 5 points 2 months ago

Actually a pretty sick discovery, nice.